On Mar. 30, 2020, the Translational Genomics Research Institute (TGen) announced that it had joined the world-wide effort to test for the SARS-CoV-2 virus causing the COVID-19 disease.

Acting as Genomic First Responders, TGen, an affiliate of City of Hope, is using advanced biomedical technologies to study this disease while also working to help establish a statewide tracking network for COVID-19.